← Leaderboards
Jose Francisco Abisambra
University Of Florida
$8,746,459
Attributed
$12,071,526
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,071,526 · 10
VA$0 · 1
By mechanism
R01$5,839,354 · 3
R33$1,817,356 · 1
R56$1,277,159 · 2
R61$1,200,370 · 1
R25$1,097,787 · 1
R21$839,500 · 2
Top collaborators
- Sara N Burke3 shared
- Karina Alvina2 shared
- David R Borchelt2 shared
- Jada M Lewis2 shared
- Paula C Bickford1 shared
- John Koren1 shared
- Jeremy Mcintyre1 shared
Most similar at University Of Florida
Same institution · by research overlap
- David Julian$2,834,396
- Rolf F Renne$15,821,379
- Diego E Rincon-Limas$5,926,703
- Vertigo Moody$530,114
- Yenisel Cruz-Almeida$13,117,222
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainTauopathiesTau ProteinsS DiseaseTherapeutic TargetProteinsLinkCognitivePathologicTau AggregationDementiaPathologyAging PopulationMediatingIn VivoMouse ModelInnovationPathogenesisImpaired CognitionNeuronal DysfunctionMolecularNeurofibrillary TanglesDesign
Grant awards (27)
Contributions of tau-mediated translational dysregulation to pathogenesis and progression of fronto-temporal dementia$544,368
R01 · FY2025 · AG · contact PI
Pathological Implications of the tau-RNA Interaction$419,375
R21 · FY2025 · AG
The molecular intersection of tau, TBI, and PERK$373,625
R01 · FY2025 · AG · contact PI
Contributions of tau-mediated translational dysregulation to pathogenesis and progression of fronto-temporal dementia$566,154
R01 · FY2024 · AG · contact PI
Networking and Expanding Undergraduate Research on the Neurobiology of Aging to Advance Diversity$389,931
R25 · FY2024 · AG
The molecular intersection of tau, TBI, and PERK$381,250
R01 · FY2024 · AG · contact PI
Contributions of tau-mediated translational dysregulation to pathogenesis and progression of fronto-temporal dementia$35,732
R01 · FY2024 · AG · contact PI
Contributions of tau-mediated translational dysregulation to pathogenesis and progression of fronto-temporal dementia$576,829
R01 · FY2023 · AG · contact PI
Networking and Expanding Undergraduate Research on the Neurobiology of Aging to Advance Diversity$386,367
R25 · FY2023 · AG
The molecular intersection of tau, TBI, and PERK$381,250
R01 · FY2023 · AG · contact PI
Contributions of tau-mediated translational dysregulation to pathogenesis and progression of fronto-temporal dementia$587,504
R01 · FY2022 · AG · contact PI
The molecular intersection of tau, TBI, and PERK$381,250
R01 · FY2022 · AG · contact PI
Networking and Expanding Undergraduate Research on the Neurobiology of Aging to Advance Diversity$321,489
R25 · FY2022 · AG
Developing new conditional models to study tauopathy, amyloidosis, and their interaction$1,817,356
R33 · FY2021 · NS
The molecular intersection of tau, TBI, and PERK$381,250
R01 · FY2021 · AG · contact PI
Identification of the Molecular Mechanisms Linking Alzheimer's Disease, PERK, and Mild Repetitive Head Injury$0
I01 · FY2021 · VA · contact PI
Developing new conditional models to study tauopathy, amyloidosis, and their interaction$1,200,370
R61 · FY2019 · NS
Exosomes from Adipose-derived Stem Cells Modulate Age-dependent Progression of Tauopathies$743,409
R56 · FY2019 · AG
Tau-mediated regulation of ribosomes in health and disease$533,750
R56 · FY2019 · NS · contact PI
PERK as a Central Mediator of Neurotoxicity in Tauopathies$333,594
R01 · FY2019 · NS · contact PI
Elucidating the pathological consequences of tau-ribosome interactions$190,625
R21 · FY2019 · NS · contact PI
PERK as a Central Mediator of Neurotoxicity in Tauopathies$324,137
R01 · FY2018 · NS · contact PI
Elucidating the pathological consequences of tau-ribosome interactions$229,499
R21 · FY2018 · NS · contact PI
Elucidating the pathological consequences of tau-ribosome interactions$1
R21 · FY2018 · NS · contact PI
PERK as a central mediator of neurotoxicity in tauopathies$324,137
R01 · FY2017 · NS · contact PI
PERK as a central mediator of neurotoxicity in tauopathies$324,137
R01 · FY2016 · NS · contact PI
PERK as a central mediator of neurotoxicity in tauopathies$324,137
R01 · FY2015 · NS · contact PI